Prostate Cancer Topics

The On-Topic Netowork

Prostate Cancer > Androgen


Androgen
Androgen
Androgen
Androgen

The following information is about Androgen.

Androgen Defined

A hormone which is responsible for male characteristics and the development and function of male sexual organs (e.g., testosterone) produced mainly by the testicles but also in the cortex of the adrenal glands; androgens have far reaching effects on blood formation, muscle and bone mass, cognitive function, emotional lability, skin and hair, etc

This definition is in context to Prostate Cancer. See more contextual defintions for Androgen.


Bostwick Therapeutics Announces Initiation of Novel Phase I/II Personalized Medicine Immunotherapy Trial for Advanced ...

Published September 5, 2008, 1:05 pm, Centre Daily Times

Bostwick Therapeutics announced today that it has received clearance from the U.S. Food and Drug Administration and the Institutional Review Board of Community Memorial Hospital, Ventura, CA., to initiate the CRITICAL (CRyotherapy and IntraTumoral Immunotherapy with immature dendritic Cells (AutoLogous)) trial, a clinical trial examining the potential of a novel combination of cryoablation and ...

Full Story


Bostwick Therapeutics Announces Initiation of Novel Phase I/II Personalized Medicine Immunotherapy Trial for Advanced ...

Published September 5, 2008, 1:00 pm, wallstreet:online AG

Bostwick Therapeutics announced today that it has received clearance from the U.S. Food and Drug Administration

Full Story


buy Propecia/Finasteride online

Published September 3, 2008, 8:02 am, KFYR-TV Bismarck

However they also WARNINGS drug, related by two in men may have to take finasteride. Reddy's trade names Fincar and within 6 weeks of finasteride decreases DHT concentrations. Discontinuation due to the physiologic range.

Full Story


Treatment May Speed Prostate Cancer

Published September 2, 2008, 12:29 pm, MedicineNet.com

Title: Treatment May Speed Prostate Cancer Category: Health News Created: 9/2/2008 Last Editorial Review: 9/2/2008

Full Story


ImClone starts patient enrolment in phase 2 study of IMC-A12 & IMC-1121B for prostate cancer

Published September 2, 2008, 5:52 am, PharmaBiz

ImClone Systems Incorporated, a global leader in the development and commercialization of novel antibodies to treat cancer, announced that its disease-directed phase-2 clinical trial in patients with advanced prostate cancer randomized to treatment with either IMC-A12 or IMC-1121B plus mitoxantrone and prednisone has commenced patient enrolment.

Full Story


Finnish Multicenter Study Comparing Intermittent To Continuous Androgen Deprivation For Advanced Prostate Cancer

Published September 2, 2008, 4:09 am, Medical News Today

UroToday.com - The FinnProstate Study VII (FPVII) is conducted as an open-label, randomized, controlled, parallel-group, multicenter clinical trial comparing intermittent and continuous ADT in patients with advanced PC.

Full Story


Novacea, Inc. and Transcept Pharmaceuticals, Inc. to Hold Conference Call to Discuss Signing of Merger Agreement

Published September 2, 2008, 4:00 am, Marketwire via Yahoo! Finance

Novacea, Inc. (NASDAQ: NOVC) and Transcept Pharmaceuticals, Inc., a privately-held specialty pharmaceutical company, announced today that they have entered into a definitive merger agreement to create a NASDAQ-listed specialty pharmaceutical company focused on developing new patient benefits from novel applications of existing prescription sleep medicine and psychiatry drugs.

Full Story


Novacea, Inc. and Transcept Pharmaceuticals, Inc. Sign Merger Agreement

Published September 1, 2008, 10:00 pm, Marketwire via Yahoo! Finance

Novacea, Inc. (NASDAQ: NOVC) and Transcept Pharmaceuticals, Inc., a privately-held specialty pharmaceutical company, announced today that they have entered into a definitive merger agreement under which Novacea will merge with Transcept in an all-stock transaction. Under the terms of the merger agreement, Novacea will issue new shares of its common stock to Transcept stockholders based on an ...

Full Story


Prostate cancer therapy reviewed

Published August 30, 2008, 10:40 am, The Intelligencer

A standard treatment for prostate cancer becomes less effective over time; now researchers think they know why.

Full Story


Are you looking for additional Prostate Cancer > Androgen news? Try our new "Androgen News Focus" area.

Off-site Androgen Links, User Submitted

The following links have been collected through user bookmark submission in the Androgen category. Please note, because these resources are off-site we cannot guarantee the accuracy or quality of any information.

Tue Sep 2

  • why does one person get acne over another?: "It is a sign of one thing and one thing only: the adolescent has oversensitive oil gland receptors overstimulated by the elevated androgen levels typical of adolescence and required for the sexual maturation at the time, and/or excess skin cell shedding within the pilosebaceous unit (pore/follicle containing the sebaceous gland) and/or weak follicular walls."

Tue Aug 12

Thu May 8

  • What is androgenetic alopecia?: Talks about how the hairline recedes to form a characteristic "M" shape and the genes associated with this condition.

Mon Apr 28

Wed Apr 16

Wed Apr 9

Mon Mar 17

Sat Mar 15

Sun Feb 10

If you would like to find additional social bookmark based links on the topic of we recommend the Open Tag Directory > Androgen. If you would like to find related tags we recommend Tag Patterns > Androgen

Off-site Androgen Research Links

If you still need additional information on Androgen then we suggest the following off-site resources. Please note, because these resources are off-site we cannot guarantee the accuracy or quality of any information.

Prostate Cancer

If you know the Prostate Cancer Term Name use the links below to quickly jump to your desired focus.



Bookmark Us

The On Topic Network

This website is part of The On Topic Network.

Thank You

Prostate-Cancer.On-Topic.net was developed by Odin Metatech, Inc and runs on the Odin Assemble platform.

Best Viewed With

License

Creative Commons License This work is licensed under Creative Commons.




Powered by Odin Assemble 2.5a